Your browser doesn't support javascript.
loading
Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication.
Vutien, Philip; Kim, Nicole J; Moon, Andrew M; Johnson, Kay M; Berry, Kristin; Green, Pamela K; Ioannou, George N.
Afiliação
  • Vutien P; Division of Gastroenterology and Hepatology, University of Washington, Seattle, Washington, USA.
  • Kim NJ; Division of Gastroenterology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
  • Moon AM; Division of Gastroenterology and Hepatology, University of Washington, Seattle, Washington, USA.
  • Johnson KM; Division of Gastroenterology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
  • Berry K; Division of Gastroenterology and Hepatology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Green PK; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Ioannou GN; Hospital and Specialty Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Aliment Pharmacol Ther ; 59(3): 361-371, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37955206

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Hepatite C Crônica / Coinfecção / Neoplasias Hepáticas Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Hepatite C Crônica / Coinfecção / Neoplasias Hepáticas Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article